At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 30, 2026 at 17:16 ET
Rocket Pharmaceuticals disclosed the resignation of VP of Finance and Principal Accounting Officer John Militello, effective July 7, 2026, to pursue other opportunities. Joseph Manhede, the company's Associate VP of Corporate Controller since April 2026, was appointed as the new Principal Accounting Officer effective July 8, 2026. This is a routine internal succession with no material financial or operational impact.
- John Militello resigned as VP of Finance, Senior Controller, Treasurer and Principal Accounting Officer, effective July 7, 2026.
- Joseph Manhede appointed as Principal Accounting Officer effective July 8, 2026.
- Manhede has served as Associate VP, Corporate Controller since April 2026 and has prior experience at Outlook Therapeutics, Amneal Pharmaceuticals, and Deloitte.
- No new compensatory arrangements were entered into with Manhede in connection with the appointment.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access